| SEC

3 Form - Initial statement of beneficial ownership of securities - NGM BIOPHARMACEUTICALS INC (0001426332) (Issuer)

SEC FORM 3SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
COLUMN GROUP III, LP

(Last)(First)(Middle)
1700 OWENS STREET
SUITE 500

(Street)
SAN FRANCISCOCA94158

(City)(State)(Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/09/2019
3. Issuer Name and Ticker or Trading Symbol
NGM BIOPHARMACEUTICALS INC [ NGM ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock53,172(1)D(2)(3)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
COLUMN GROUP III, LP

(Last)(First)(Middle)
1700 OWENS STREET
SUITE 500

(Street)
SAN FRANCISCOCA94158

(City)(State)(Zip)
1. Name and Address of Reporting Person*
COLUMN GROUP III-A, LP

(Last)(First)(Middle)
1700 OWENS STREET
SUITE 500

(Street)
SAN FRANCISCOCA94158

(City)(State)(Zip)
1. Name and Address of Reporting Person*
COLUMN GROUP III GP, LP

(Last)(First)(Middle)
1700 OWENS STREET
SUITE 500

(Street)
SAN FRANCISCOCA94158

(City)(State)(Zip)
Explanation of Responses:
1. Consists of 24,972 shares of Common Stock held directly by The Column Group III, LP ("TCG III LP") and 28,200 shares of Common Stock held directly by The Column Group III-A, LP ("TCG III-A LP").
2. The securities are directly held by TCG III LP, and indirectly held by The Column Group III GP, LP ("TCG III GP"), the general partner of TCG III LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
3. The securities are directly held by TCG III-A LP, and indirectly held by TCG III GP, the general partner of TCG III-A LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
/s/ Jennifer J. Carlson, Attorney-in-Fact10/11/2019
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Comments

dispatchtribune-profile-image
Dispatch Tribunal @dispatchtribune - 14 minutes ago
NGM Biopharmaceuticals $NGM Major Shareholder Group L. P. Column Acquires 103,000 Shares https://t.co/IlBmbVvfda
HeadlinesFin-profile-image
FinHeadlines @HeadlinesFin - 5 hours ago
After Today's Huge Increase, Is NGM Biopharmaceuticals, Inc. $NGM's Near-Term Analysis Positive? https://t.co/39FD519ZcI
bihan35-profile-image
bihan35 @bihan35 - 5 hours ago
RT @HCWCO: Companies like $POXEL, $NGM, $MDGL, $LPCN, and $LMNL will share presentations at #HCWCO's Nash Investor Conference on developmen…
BlueBioNow-profile-image
Blue Healthcare Now @BlueBioNow - 8 hours ago
$NGM I'll have my bear burger medium rare with mushroom and swiss please. 5.45 % change recently https://t.co/a08c4PQ76Q
AlertTrade-profile-image
Trade Alerts, Trade Ideas and Crypto 📈 @AlertTrade - 9 hours ago
SOCIAL ACTIVITY: $NGM 📈 TradeIdeas via ➡ https://t.co/VS8RO1bzXJ
AlertTrade-profile-image
Trade Alerts, Trade Ideas and Crypto 📈 @AlertTrade - 9 hours ago
RT @theflynews: Fly Intel: Top five analyst initiations $NGM $ARQL $TXMD $AQN $TAL https://t.co/sR6IpIHzNy
theflynews-profile-image
The Fly @theflynews - 9 hours ago
Fly Intel: Top five analyst initiations $NGM $ARQL $TXMD $AQN $TAL https://t.co/sR6IpIHzNy
TradeCNBC-profile-image
TradeCNBC @TradeCNBC - 10 hours ago
RT @OpenOutcrier: +Initiations 10/17: $ALXN $AQN $ARQL $AZRE $BMRN $BMY $CDMO $CPB $CTLT $HLT $HST $IDYA $LLY $MBRX $MDLZ $NGM $REPH $TAL $…
TradeCNBC-profile-image
TradeCNBC @TradeCNBC - 10 hours ago
RT @Quantumup1: B. Riley FBR initiates coverage of $NGM with a Buy rating, $24 PT https://t.co/eU653rZx7n
Quantumup1-profile-image
quantumup @Quantumup1 - 10 hours ago
B. Riley FBR initiates coverage of $NGM with a Buy rating, $24 PT https://t.co/eU653rZx7n
OpenOutcrier-profile-image
Open Outcrier @OpenOutcrier - 11 hours ago
+Initiations 10/17: $ALXN $AQN $ARQL $AZRE $BMRN $BMY $CDMO $CPB $CTLT $HLT $HST $IDYA $LLY $MBRX $MDLZ $NGM $REPH… https://t.co/bqtYWYNioV
newsfilterio-profile-image
newsfilter.io @newsfilterio - 11 hours ago
Gabelli likes Teva in premarket analyst action $CDMO $NGM $REPH $TEVA https://t.co/BMB3nzqFTw
MarketCurrents-profile-image
Breaking News @MarketCurrents - 11 hours ago
$CDMO $NGM $REPH - Gabelli likes Teva in premarket analyst action https://t.co/kFS1p62g9T
TickerReport-profile-image
Ticker Report @TickerReport - 12 hours ago
NGM Biopharmaceuticals $NGM Now Covered by Analysts at B. Riley https://t.co/wDRh0m3RzG
Briefingcom-profile-image
Briefing.com @Briefingcom - 13 hours ago
$NGM: B. Riley FBR starts at Buy